News & Events
What’s Missing from Innovation?
Venture capital funding is a fraction of the research funds being spent by big firms on e-health (more than $12 billion). That kind of money raises interesting questions …
The Perfect Match Might Be the Imperfect One
When it comes to treating blood cancers like leukemia and lymphomas, new research shows that a half-matched donor bone marrow transplant may be just as good as a full match, in the first apples to apples type comparison of its kind.
Aria Health & Jefferson Sign Letter of Intent
Aria, Jefferson to team up to provide seamless care experience, continue transformation of healthcare for patients across southeast Pennsylvania and southern New Jersey.
A Doctor Just for Girls
Beth Schwartz joins Jefferson and Nemours as a specialist in pediatric and adolescent gynecology to help families address girls’ needs from birth to early adulthood.
Arteries Better Than Veins for Liquid Biopsy
Arteries contain higher numbers of circulating tumor cells than veins in uveal melanoma patients, raising a concern for standard technique for detection of tumor cells in the blood.
One Size Doesn’t Fit All: Patients with Metastatic Cancer May Need Stronger Anti-Coagulation Therapy Following Bone Lesion Surgery
Jefferson researchers identified a high risk for venous thromboembolism (VTE), or blood clots, following surgery for long-bone reconstruction in patients with metastatic cancer.
Genomic Analysis for All Cancer Patients
Jefferson expands its cancer treatment to analyze each cancer patient's tumor with the newest techniques and help doctors identify cutting edge treatment options.
Simple Test Predicts Obstructive Sleep Apnea in Patients Hospitalized for Heart Failure
Sunil Sharma, M.D. and his team showed that a simple questionnaire, evaluation and pulse-oximetry monitoring can lead to early detection of sleep apnea in patients hospitalized for congestive heart failure.
High Use of Alternative Medicine in Senior Oncology Patients
Many seniors with cancer are also using complementary or alternative medicines that could interfere with their cancer treatment.
Thomas Jefferson University Launches Interactive Curricula Experience
New Curriculum Platform uses iPads to Meet Students Where They Are – On Mobile Devices